Literature DB >> 22488550

Taller women are at greater risk of recurrent venous thromboembolism: the Iowa Women's Health Study.

Pamela L Lutsey1, Aaron R Folsom.   

Abstract

Venous thromboembolism (VTE) recurs frequently. Greater height is associated with increased risk of incident VTE, but it is unclear whether height is related to risk of VTE recurrence. Recurrent VTE is associated with substantial morbidity and mortality, thus identifying individuals at greatest risk of experiencing a recurrent event, who may benefit from extended anticoagulant therapy, is vitally important. Using data from the Iowa Women,s Health Study, we explored whether greater height was associated with increased risk of VTE recurrence.Among 1,691 women who experienced an initial VTE event, 286(16.9%) experienced a recurrent event. Risk of recurrence was 76%(95% CI: 16% -186%) higher among women >66 inches [168 cm] tall relative to those ≤62 inches [158 cm] tall, after adjustment for age and waist circumference. Future research should evaluate whether body height improves clinical prediction of VTE recurrence risk.

Entities:  

Mesh:

Year:  2012        PMID: 22488550      PMCID: PMC3375396          DOI: 10.1002/ajh.23199

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  24 in total

1.  Venous pressure dynamics of the healthy human leg. Role of muscle activity, joint mobility and anthropometric factors.

Authors:  C Kügler; M Strunk; G Rudofsky
Journal:  J Vasc Res       Date:  2001 Jan-Feb       Impact factor: 1.934

2.  Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.

Authors:  Sabine Eichinger; Georg Heinze; Lisanne M Jandeck; Paul A Kyrle
Journal:  Circulation       Date:  2010-03-29       Impact factor: 29.690

3.  Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

Authors:  J A Heit; D N Mohr; M D Silverstein; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

4.  Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE).

Authors:  Pamela L Lutsey; Mary Cushman; Susan R Heckbert; Weihong Tang; Aaron R Folsom
Journal:  Thromb Haemost       Date:  2011-06-09       Impact factor: 5.249

Review 5.  Risk assessment for recurrent venous thrombosis.

Authors:  Paul Alexander Kyrle; Frits R Rosendaal; Sabine Eichinger
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

6.  Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study.

Authors:  Marianne Tang Severinsen; Søren Paaske Johnsen; Anne Tjønneland; Kim Overvad; Claus Dethlefsen; Søren Risom Kristensen
Journal:  Eur J Intern Med       Date:  2010-04-28       Impact factor: 4.487

7.  Short stature and coronary heart disease: a 35-year follow-up of the Finnish cohorts of The Seven Countries Study.

Authors:  T Forsén; J Eriksson; Q Qiao; M Tervahauta; A Nissinen; J Tuomilehto
Journal:  J Intern Med       Date:  2000-10       Impact factor: 8.989

Review 8.  Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.

Authors:  M Rodger; M Carrier; E Gandara; G Le Gal
Journal:  Blood Rev       Date:  2010-07-14       Impact factor: 8.250

Review 9.  The absence of 'minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios.

Authors:  K Meijer; S Schulman
Journal:  J Thromb Haemost       Date:  2009-07-17       Impact factor: 5.824

10.  Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study.

Authors:  Pamela L Lutsey; Beth A Virnig; Sara B Durham; Lyn M Steffen; Alan T Hirsch; David R Jacobs; Aaron R Folsom
Journal:  Am J Public Health       Date:  2009-11-12       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.